RALEIGH, N.C.--(BUSINESS WIRE)--NephroGenex, Inc. (Nasdaq: NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, will report financial results for the quarter ended September 30, 2015 on Wednesday, November 11, after the U.S. financial markets close. The Company will host a conference call and webcast the following day, Thursday, November 12, at 8:30 a.m. EST, to review third quarter results and provide an update on its PIONEER program for diabetic nephropathy and upcoming milestones.
Help employers find you! Check out all the jobs and post your resume.